- Home
- FENG vs ANTX Comparison
FENG vs ANTX Comparison
Compare FENG & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- ANTX
- Stock Information
- Founded
- FENG 1998
- ANTX 2017
- Country
- FENG China
- ANTX United States
- Employees
- FENG N/A
- ANTX N/A
- Industry
- FENG Broadcasting
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- FENG Industrials
- ANTX Health Care
- Exchange
- FENG Nasdaq
- ANTX Nasdaq
- Market Cap
- FENG 26.8M
- ANTX 31.4M
- IPO Year
- FENG 2011
- ANTX 2022
- Fundamental
- Price
- FENG $2.66
- ANTX $1.29
- Analyst Decision
- FENG
- ANTX Buy
- Analyst Count
- FENG 0
- ANTX 2
- Target Price
- FENG N/A
- ANTX $2.00
- AVG Volume (30 Days)
- FENG 19.2K
- ANTX 80.6K
- Earning Date
- FENG 11-11-2025
- ANTX 11-12-2025
- Dividend Yield
- FENG N/A
- ANTX N/A
- EPS Growth
- FENG N/A
- ANTX N/A
- EPS
- FENG N/A
- ANTX N/A
- Revenue
- FENG $101,168,374.00
- ANTX N/A
- Revenue This Year
- FENG N/A
- ANTX N/A
- Revenue Next Year
- FENG N/A
- ANTX N/A
- P/E Ratio
- FENG N/A
- ANTX N/A
- Revenue Growth
- FENG 5.53
- ANTX N/A
- 52 Week Low
- FENG $1.28
- ANTX $0.98
- 52 Week High
- FENG $3.49
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- FENG 59.09
- ANTX 62.56
- Support Level
- FENG $2.51
- ANTX $1.22
- Resistance Level
- FENG $2.68
- ANTX $1.33
- Average True Range (ATR)
- FENG 0.22
- ANTX 0.08
- MACD
- FENG 0.01
- ANTX 0.01
- Stochastic Oscillator
- FENG 55.17
- ANTX 85.71
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.